In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of chemotherapy to standard treatment cuts the risk of death by 40%.

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in a significant increase in survival rates, a new study shows.

A short course of chemotherapy given before conventional treatment significantly cuts the risk of dying from cervical cancer, according to new study results.

A new treatment regime for cervical cancer cuts the risk of death by 40%, according to a large-scale study.Researchers at University College London (UCL) and University College London Hospital (UCLH) have completed a long-term follow up of patients given a short course of chemotherapy before chemoradiation (a combination of chemotherapy and radiotherapy).

Adding the drug nivolumab to AVD therapy halves the rate of cancer progression or death for blood cancer patients, compared to the former protocol of AVD plus, according to a new study. The new "N-AVD" treatment also has less onerous side effects than the prior regimen,